BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23376579)

  • 21. Leveraging H1N1 infection transmission modeling with proximity sensor microdata.
    Hashemian M; Stanley K; Osgood N
    BMC Med Inform Decis Mak; 2012 May; 12():35. PubMed ID: 22551391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiologic parameters and evaluation of control measure for 2009 novel influenza a (H1N1) in Xiamen, Fujian Province, China.
    Shen J; Niu J
    Virol J; 2012 Jan; 9():20. PubMed ID: 22248240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individual Vaccination as Nash Equilibrium in a SIR Model with Application to the 2009-2010 Influenza A (H1N1) Epidemic in France.
    Laguzet L; Turinici G
    Bull Math Biol; 2015 Oct; 77(10):1955-84. PubMed ID: 26443437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal control of vaccination dynamics during an influenza epidemic.
    Jaberi-Douraki M; Moghadas SM
    Math Biosci Eng; 2014 Oct; 11(5):1045-63. PubMed ID: 25347806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling optimal age-specific vaccination strategies against pandemic influenza.
    Lee S; Golinski M; Chowell G
    Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution epidemic simulation using within-host infection and contact data.
    Nguyen VK; Mikolajczyk R; Hernandez-Vargas EA
    BMC Public Health; 2018 Jul; 18(1):886. PubMed ID: 30016958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything.
    Conway JM; Tuite AR; Fisman DN; Hupert N; Meza R; Davoudi B; English K; van den Driessche P; Brauer F; Ma J; Meyers LA; Smieja M; Greer A; Skowronski DM; Buckeridge DL; Kwong JC; Wu J; Moghadas SM; Coombs D; Brunham RC; Pourbohloul B
    BMC Public Health; 2011 Dec; 11():932. PubMed ID: 22168242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling the initial phase of an epidemic using incidence and infection network data: 2009 H1N1 pandemic in Israel as a case study.
    Katriel G; Yaari R; Huppert A; Roll U; Stone L
    J R Soc Interface; 2011 Jun; 8(59):856-67. PubMed ID: 21247949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemic modelling: aspects where stochasticity matters.
    Britton T; Lindenstrand D
    Math Biosci; 2009 Dec; 222(2):109-16. PubMed ID: 19837097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prioritization of vaccine strategy using an age-dependent mathematical model for 2009 A/H1N1 influenza in the Republic of Korea.
    Kim S; Jung E
    J Theor Biol; 2019 Oct; 479():97-105. PubMed ID: 31330133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian estimation of the dynamics of pandemic (H1N1) 2009 influenza transmission in Queensland: A space-time SIR-based model.
    Huang X; Clements AC; Williams G; Mengersen K; Tong S; Hu W
    Environ Res; 2016 Apr; 146():308-14. PubMed ID: 26799511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010.
    Van Effelterre T; Dos Santos G; Shinde V
    PLoS One; 2016; 11(3):e0151575. PubMed ID: 27010830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating transmission probability in schools for the 2009 H1N1 influenza pandemic in Italy.
    Clamer V; Dorigatti I; Fumanelli L; Rizzo C; Pugliese A
    Theor Biol Med Model; 2016 Oct; 13(1):19. PubMed ID: 27729047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Edge-based epidemic spreading in degree-correlated complex networks.
    Wang Y; Ma J; Cao J; Li L
    J Theor Biol; 2018 Oct; 454():164-181. PubMed ID: 29885412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Overview of the 2009 A(H1N1) Pandemic in Europe: Efficiency of the Vaccination and Healthcare Strategies.
    Samanlioglu F; Bilge AH
    J Healthc Eng; 2016; 2016():. PubMed ID: 27195658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of social contact patterns and demographic factors on influenza simulation results.
    Schmidt-Ott R; Schwehm M; Eichner M
    BMC Infect Dis; 2016 Nov; 16(1):646. PubMed ID: 27821137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mathematical models of transmission dynamics and vaccine strategies in Hong Kong during the 2017-2018 winter influenza season.
    Ho SH; He D; Eftimie R
    J Theor Biol; 2019 Sep; 476():74-94. PubMed ID: 31128142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of illness on social networks: implications for transmission and control of influenza.
    Van Kerckhove K; Hens N; Edmunds WJ; Eames KT
    Am J Epidemiol; 2013 Dec; 178(11):1655-62. PubMed ID: 24100954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Bartsch SM; Taitel MS; DePasse JV; Cox SN; Smith-Ray RL; Wedlock P; Singh TG; Carr S; Siegmund SS; Lee BY
    Vaccine; 2018 Nov; 36(46):7054-7063. PubMed ID: 30340884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
    Puleston RL; Bugg G; Hoschler K; Konje J; Thornton J; Stephenson I; Myles P; Enstone J; Augustine G; Davis Y; Zambon M; Nicholson KG; Nguyen-Van-Tam JS
    Health Technol Assess; 2010 Dec; 14(55):1-82. PubMed ID: 21208547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.